[Invasive cardiology: focus on restenosis. Part II].
In-stent restenosis represents a pathological process which histology is different from that of restenosis after balloon angioplasty. In-stent restenosis is mainly caused by neointima proliferation. This part of review deals with technologies of prevention of in-stent restenosis including novel stent designs and coatings aimed at suppression of neointima proliferation.
Belenkov
Iu N
IuN
Batyraliev
T A
TA
Pershukov
I V
IV
Samko
A N
AN
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D023903:Coronary Restenosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D011341:Probucol / Q000627:therapeutic use; D015607:Stents
D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D011341:Probucol